Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.
Peter JacobyCatherine GloverChloe DamonParveen FathimaAlexis PillsburyDavid DurrheimMichael S GoldAlan LeebTom SnellingPublished in: BMJ open (2020)
Active vaccine safety surveillance leading to rapid detection of a safety signal would likely have resulted in earlier suspension of Fluvax from the vaccination programme, prevention of many febrile convulsions and maintenance of public confidence in influenza vaccination for young children.